alscarmuzza
Established Member
- Reaction score
- 127
C Chu1 , C Yang1 , L Lin2 , M Hughes3 and Y Tsai4 1 Department of Dermatology, National Cheng Kung University Hospital, Tainan, Taiwan, 2 Yuan’s Dermatology Clinic, Taichung, Taiwan, 3 International Research Center for Wound Repair and Regeneration, National Cheng Kung University, Tainan, Taiwan and 4 Institute of Clinical Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
Leptin, one of the major signaling molecules from white adipose tissues, has been reported to modulate the growth of hair follicles. Obesity is linked with greater severity of androgenetic alopecia (Androgenetic Alopecia) suggesting that metabolic factors, including leptin, play a role in hair loss diseases. This study aims to investigate the role of leptin in the pathogenesis of Androgenetic Alopecia. Leptin can reach the hair follicle via the systemic circulation and from the local adipose tissue of skin. Therefore we first evaluate the relation between plasma leptin level with the severity and risk of Androgenetic Alopecia in men. In 29 Androgenetic Alopecia and 19 non-Androgenetic Alopecia subjects, the plasma leptin level was significantly higher in Androgenetic Alopecia subjects compared to non-Androgenetic Alopecia subjects (4.45 vs. 2.76 ng/ml, P < 0.05). Higher plasma leptin levels were associated with a greater risk of developing Androgenetic Alopecia after controlling for age and body mass index of the subjects (odds ratio¼ 2.77, P < 0.05). Then we evaluate the gene expression pattern in the adipose tissue of normal (occipital) scalp and bald (frontal) scalp from the same individual. Leptin mRNA expression was significantly lower in the adipose tissue from bald scalp compared to normal scalp (n¼8, P < 0.01). The expression of BMP-2 gene in the adipose tissue is significantly higher in the bald scalp then then normal scalp (n¼7, P < 0.05). Although leptin showed differential expression in bald vs. normal scalp and Androgenetic Alopecia vs. non-Androgenetic Alopecia subjects, further research is warranted to elucidate the clinical implication of leptin in Androgenetic Alopecia.
Leptin, one of the major signaling molecules from white adipose tissues, has been reported to modulate the growth of hair follicles. Obesity is linked with greater severity of androgenetic alopecia (Androgenetic Alopecia) suggesting that metabolic factors, including leptin, play a role in hair loss diseases. This study aims to investigate the role of leptin in the pathogenesis of Androgenetic Alopecia. Leptin can reach the hair follicle via the systemic circulation and from the local adipose tissue of skin. Therefore we first evaluate the relation between plasma leptin level with the severity and risk of Androgenetic Alopecia in men. In 29 Androgenetic Alopecia and 19 non-Androgenetic Alopecia subjects, the plasma leptin level was significantly higher in Androgenetic Alopecia subjects compared to non-Androgenetic Alopecia subjects (4.45 vs. 2.76 ng/ml, P < 0.05). Higher plasma leptin levels were associated with a greater risk of developing Androgenetic Alopecia after controlling for age and body mass index of the subjects (odds ratio¼ 2.77, P < 0.05). Then we evaluate the gene expression pattern in the adipose tissue of normal (occipital) scalp and bald (frontal) scalp from the same individual. Leptin mRNA expression was significantly lower in the adipose tissue from bald scalp compared to normal scalp (n¼8, P < 0.01). The expression of BMP-2 gene in the adipose tissue is significantly higher in the bald scalp then then normal scalp (n¼7, P < 0.05). Although leptin showed differential expression in bald vs. normal scalp and Androgenetic Alopecia vs. non-Androgenetic Alopecia subjects, further research is warranted to elucidate the clinical implication of leptin in Androgenetic Alopecia.